Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Essential,Hypertension”

Showing 20 of 0 results

Not applicableUnknownNCT00380289
What this trial is testing

Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension

Who this might be right for
Essential Hypertension
University of Cambridge 66
Large-scale testing (Phase 3)Study completedNCT01299376
What this trial is testing

MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)

Who this might be right for
Hypertension
Merck Sharp & Dohme LLC 286
Large-scale testing (Phase 3)Study completedNCT07564726
What this trial is testing

Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

Who this might be right for
HypertensionHypercholesterolemia
Celltrion Pharm, Inc. 163
Not applicableStudy completedNCT02336607
What this trial is testing

The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.

Who this might be right for
Hypertension
AstraZeneca 529
Early research (Phase 1)Study completedNCT01289899
What this trial is testing

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 16
Testing effectiveness (Phase 2)Study completedNCT00153049
What this trial is testing

3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 583
Post-approval studies (Phase 4)UnknownNCT00366119
What this trial is testing

Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension

Who this might be right for
Essential Hypertension
Pacific Pharmaceuticals 86
Early research (Phase 1)Study completedNCT06889064
What this trial is testing

Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 28
Early research (Phase 1)Study completedNCT01523067
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension

Who this might be right for
Essential Hypertension
PhaseBio Pharmaceuticals Inc. 68
Not applicableStudy completedNCT04788563
What this trial is testing

Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community

Who this might be right for
Primary Hypertension
Jiangxi University of Traditional Chinese Medicine 400
Post-approval studies (Phase 4)Study completedNCT02242370
What this trial is testing

Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 3,045
Large-scale testing (Phase 3)Study completedNCT00922480
What this trial is testing

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 506
Post-approval studies (Phase 4)Study completedNCT00931710
What this trial is testing

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

Who this might be right for
Stage 2 Systolic Hypertension
Novartis 488
Post-approval studies (Phase 4)UnknownNCT05880056
What this trial is testing

Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Genuine Research Center, Egypt 406
Large-scale testing (Phase 3)Study completedNCT01033071
What this trial is testing

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Who this might be right for
Essential Hypertension
Takeda 1,071
Large-scale testing (Phase 3)Study completedNCT00778921
What this trial is testing

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone

Who this might be right for
Hypertension
Novartis 847
Large-scale testing (Phase 3)Study completedNCT00865501
What this trial is testing

Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease

Who this might be right for
Primary Hypertension
University of Erlangen-Nürnberg Medical School 50
Large-scale testing (Phase 3)Study completedNCT00160277
What this trial is testing

Efficacy and Safety of Moxonidine in Indian Patients

Who this might be right for
Hypertension
Solvay Pharmaceuticals 100
Not applicableWithdrawnNCT01884298
What this trial is testing

Effect of Different Anesthetic Techniques for Isolated Systolic Hypertensive Patients of Abdominal Surgery on Postoperative Hospital Stay and Morbidity

Who this might be right for
Postoperative Complications
Peking University First Hospital
Testing effectiveness (Phase 2)Ended earlyNCT00444834
What this trial is testing

Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension

Who this might be right for
Hypertension
Egalet Ltd 14
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation